latest news releases from the newsroom
Penwest Pharmaceuticals Co.
Penwest Begins Phase Ia Clinical Trial of A0001, a Compound For Treatment of Mitochondrial Diseases
DANBURY, Conn., July 14, 2008 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has begun dosing in a Phase Ia clinical trial of A0001, a compound the Company is developing for the treatment of symptoms associated with mitochondrial diseases. Mitochondrial diseases are devastating illnesses that often occur during childhood and currently have no FDA approved treatments.
Entegris to Acquire Poco Graphite
CHASKA, Minn., July 14, 2008 (PRIME NEWSWIRE) -- Entegris, Inc. (Nasdaq:ENTG) today announced that it has signed a definitive agreement to acquire privately held Poco Graphite, Inc., in an all-cash transaction valued at $158 million.
RedChip Companies Inc.
RedChip Companies, Inc. Partners with German-based Small-Cap News
ORLANDO, Fla., July 14, 2008 (PRIME NEWSWIRE) -- RedChip Companies, Inc., an international financial public relations firm, today announced a new partnership with Small-Cap News, a German-based small-cap investor relations firm that offers a comprehensive base of public relations services for emerging growth companies. The partnership extends RedChip's investor relations services to target the German investor market.